BEKSAÇ, M. Et Al. 2021. Safety of Daratumumab Combined with Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Patients with Multiple Myeloma Presenting with Extramedullary Disease during the COVID-19 Pandemic. 63rd ASH Annual Meeting and Exposition , (United States Of America).

BEKSAÇ, M., TUĞLULAR, T., ÜNAL, A., Cavo, M., Gay, F., KATODRITOU, E., ... ÖZSAN, G. H.(2021). Safety of Daratumumab Combined with Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Patients with Multiple Myeloma Presenting with Extramedullary Disease during the COVID-19 Pandemic . 63rd ASH Annual Meeting and Exposition, United States Of America

BEKSAÇ, MERAL Et Al. "Safety of Daratumumab Combined with Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Patients with Multiple Myeloma Presenting with Extramedullary Disease during the COVID-19 Pandemic," 63rd ASH Annual Meeting and Exposition, United States Of America, 2021

BEKSAÇ, MERAL Et Al. "Safety of Daratumumab Combined with Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Patients with Multiple Myeloma Presenting with Extramedullary Disease during the COVID-19 Pandemic." 63rd ASH Annual Meeting and Exposition , United States Of America, 2021

BEKSAÇ, M. Et Al. (2021) . "Safety of Daratumumab Combined with Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Patients with Multiple Myeloma Presenting with Extramedullary Disease during the COVID-19 Pandemic." 63rd ASH Annual Meeting and Exposition , United States Of America.

@conferencepaper{conferencepaper, author={MERAL BEKSAÇ Et Al. }, title={Safety of Daratumumab Combined with Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Patients with Multiple Myeloma Presenting with Extramedullary Disease during the COVID-19 Pandemic}, congress name={63rd ASH Annual Meeting and Exposition}, city={}, country={United States Of America}, year={2021}}